7-Sep-2011
Other Events, Financial Statements and Exhibits
Item 8.01. Other Events.
On September 6, 2011, the Company issued a press release announcing that the Nasdaq Listing Qualifications Hearings Panel granted the Company's request for continued listing of its common stock on The Nasdaq Capital Market, subject to satisfaction of certain conditions by December 31, 2011, including implementation of a reverse stock split sufficient to allow the stock to trade above $4.00, completion of the Company's planned merger with Allozyne, Inc. and approval from Nasdaq of the combined entity's application for initial listing on The Nasdaq Capital Market upon completion of the merger.
A copy of the Company's press release is attached hereto as Exhibit 99.1 and incorporated herein by reference, specifically including the cautionary note regarding forward-looking statements contained in the press release.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
99.1 - Press release dated September 6, 2011